SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014082
Filing Date
2023-08-09
Accepted
2023-08-09 07:30:39
Documents
94
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ipsc-20230630x10q.htm   iXBRL 10-Q 1865342
2 EX-31.1 ipsc-20230630xex31d1.htm EX-31.1 13627
3 EX-31.2 ipsc-20230630xex31d2.htm EX-31.2 13441
4 EX-32.1 ipsc-20230630xex32d1.htm EX-32.1 6975
5 EX-32.2 ipsc-20230630xex32d2.htm EX-32.2 6943
  Complete submission text file 0001558370-23-014082.txt   8808250

Data Files

Seq Description Document Type Size
6 EX-101.SCH ipsc-20230630.xsd EX-101.SCH 63270
7 EX-101.CAL ipsc-20230630_cal.xml EX-101.CAL 67831
8 EX-101.DEF ipsc-20230630_def.xml EX-101.DEF 230129
9 EX-101.LAB ipsc-20230630_lab.xml EX-101.LAB 542950
10 EX-101.PRE ipsc-20230630_pre.xml EX-101.PRE 426339
88 EXTRACTED XBRL INSTANCE DOCUMENT ipsc-20230630x10q_htm.xml XML 1610219
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40498 | Film No.: 231153386
SIC: 2836 Biological Products, (No Diagnostic Substances)